Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12420559 | 1.00 | CYP2C9 (0.38) | CYP2C9 | |
| SCHEMBL12508912 | 1.00 | CYP2C9 (0.38) | CYP2C9 | |
| SCHEMBL21147695 | 1.00 | CYP2C9 (0.38) | CYP2C9 | |
| SCHEMBL10457153 | 0.73 | CYP2C9 (0.42) | CYP2C9 | |
| SCHEMBL12765620 | 0.73 | — | — | |
| SCHEMBL8781694 | 0.71 | — | — | |
| SCHEMBL13742599 | 0.69 | — | — | |
| SCHEMBL31167963 | 0.69 | — | — | |
| SCHEMBL4064503 | 0.69 | CYP2C9 (0.38) | CYP2C9 | |
| SCHEMBL871897 | 0.69 | CYP2C9 (0.38) | CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105906567-A | Fungicidal N-Bicycloalkyl And N-Tricycloalkyl (Thio)Carboxamide Derivatives | 拜耳知识产权有限责任公司 | 2016-08-31 | — | — | CN | claimed |
| JP-6040996-A | — | — | None | — | — | JP | disclosed |
| JP-3072489-A | — | — | None | — | — | JP | disclosed |
| EP-4614646-A1 | SOLID ELECTROLYTE LAMINATE, SOLID SECONDARY BATTERY, AND PRODUCTION METHOD FOR SAME | Nissan Motor Co., Ltd. (JP) | 2025-09-10 | — | — | EP | disclosed |
| CN-120153508-A | Solid electrolyte laminate, solid secondary battery, and method for producing same | 日产自动车株式会社 | 2025-06-13 | — | — | CN | disclosed |
| WO-2024096065-A1 | SOLID ELECTROLYTE LAMINATE, SOLID SECONDARY BATTERY, AND PRODUCTION METHOD FOR SAME | 日産自動車株式会社 | 2024-05-10 | — | — | WO | disclosed |
| US-20230144767-A1 | TARGETED NITROXIDE AGENTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2023-05-11 | — | — | US | disclosed |
| CN-113121574-B | Purine derivatives and their use in medicine | 成都百裕制药股份有限公司 | 2023-02-17 | — | — | CN | disclosed |
| US-20210371460-A1 | TARGETED NITROXIDE AGENTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2021-12-02 | — | — | US | disclosed |
| US-20210371460-A1 | TARGETED NITROXIDE AGENTS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2021-12-02 | — | — | US | disclosed |
| EP-0368946-B1 | 1,2-DIOXETANES | TROPIX INC (US) | 1994-09-14 | — | — | EP | disclosed |
| JP-H0640996-A | INTERMEDIATE FOR PRODUCTION OF 1,2-DIOXETANE COMPOUND | TROPIX INC | 1994-02-15 | — | — | JP | disclosed |
| EP-0582317-A2 | Synthesis of 1,2-dioxetanes and intermediates therefor | TROPIX, INC. (US) | 1994-02-09 | — | — | EP | disclosed |
| US-5177241-A | SYNTHESIS OF 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | APPLIED BIOSYSTEMS, LLC | 1993-01-05 | — | — | US | disclosed |
| JP-H0372489-A | 1,2-DIOXETANE COMPOUND | TROPIX INC | 1991-03-27 | — | — | JP | disclosed |
| US-4956477-A | Synthesis of 1,2-dioxetanes | TROPIX, INC. (US) | 1990-09-11 | — | — | US | disclosed |
| EP-0368946-A1 | 1,2-DIOXETANES. | QUEST SYSTEMS INC (US) | 1990-05-23 | — | — | EP | disclosed |
| EP-0368946-A4 | 1,2-DIOXETANES. | QUEST SYSTEMS INC (US) | 1990-05-14 | — | — | EP | disclosed |
| WO-1989006226-A1 | SYNTHESIS OF 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | QUEST SYSTEMS, INC. (US) | 1989-07-13 | — | — | WO | disclosed |
| EP-0178668-A2 | Process for preparing rimantadine | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230144767-A1 | TARGETED NITROXIDE AGENTS | TXNRD2, TXN2, HSPE1 | CYP2C9 908/4885 |
| US-20210371460-A1 | TARGETED NITROXIDE AGENTS | TXNRD2, TXN2, HSPE1 | CYP2C9 908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.